Tubize-Fin（TUB.BR）— 同类公司组
数据截至2026-10-30 — 评分每个交易日晚间重新计算。分组标准＝首先为共同的Closelook指数成分，其次为行业。Closelook研究日记，不构成投资建议。
Tubize-Fin的Closelook综合评分为31/100，在同类公司组内排名第7位（共7家）——组内评分最高的是BB Biotech AG（74/100）。
| 名称 | 综合 | 动量 | 质量 | 估值 | 信号 | 距52周高点 |
|---|---|---|---|---|---|---|
| TUB.BR Tubize-Fin | 31 | 63 | 21 | 24 | info | 7.9% |
| BION.SW BB Biotech AG | 74 | 71 | 96 | 81 | info | 10% |
| HALO Halozyme Therapeutics Inc | 73 | 98 | 94 | 39 | ok | 2.3% |
| ONC BeiGene, Ltd. | 65 | 86 | 64 | 31 | ok | 4.7% |
| UCB.BR UCB SA | 65 | 70 | 71 | 54 | info | 2.4% |
| ARGX.BR Argen-X | 64 | 79 | 75 | 29 | info | 12.7% |
| ARGX argenx NV ADR | 63 | 73 | 74 | 29 | info | 16.8% |
FAQ · from the current data · as of 2026-10-30
Quick answers
Tubize-Fin在Closelook覆盖范围内的同类公司有哪些？
分组首先基于共同的Closelook指数成分，其次基于行业：BB Biotech AG (BION.SW)、Halozyme Therapeutics Inc (HALO)、BeiGene, Ltd. (ONC)、UCB SA (UCB.BR)、Argen-X (ARGX.BR)、argenx NV ADR (ARGX)。
TUB.BR相对同类公司的评分如何？
Tubize-Fin的综合评分为31/100，组内排名第7位（共7家），截至2026-10-30；组内最高综合评分为BB Biotech AG（74/100）。Closelook评分为研究日记读数，不构成评级或投资建议。
Related in the Closelooknet universe
then Biotechnology. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.
- BION.SW BB Biotech AGindustry
- HALO Halozyme Therapeutics Incindustry
- ONC BeiGene, Ltd.industry
- UCB.BR UCB SAindustry
- ARGX.BR Argen-Xindustry
- ARGX argenx NV ADRindustry
- KOD Kodiak Sciences Incindustry
- REPL Replimune Group Incindustry
- MRNA Moderna Incindustry
- ARQT Arcutis Biotherapeutics Incindustry
- DNA Ginkgo Bioworks Holdingsindustry
- ABSI Absci Corpindustry
- EXEL Exelixis Incindustry
- ONT.L Oxford Nanopore Technologies Ltdindustry
- XNCR Xencor Incindustry
- ALK-B.CO ALK-Abelló A/Sindustry
- ADMA ADMA Biologics Incindustry
- VRDN Viridian Therapeutics Incindustry
- IRON Disc Medicine Inc.industry
- BHVN Biohaven Ltd.industry